Published in Z Lebensm Unters Forsch on November 01, 1984
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Conformational studies of peptides corresponding to the coeliac-activating regions of wheat alpha-gliadin. Biochem J (1990) 0.90
Cereal chemistry, molecular biology, and toxicity in coeliac disease. Gut (1991) 0.84
Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients. Clin Exp Immunol (1989) 0.79
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (1997) 6.82
Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem (1996) 6.22
Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ (2003) 3.66
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity (2000) 3.45
Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol (2000) 2.78
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med (2001) 2.66
New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene (2010) 2.56
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem (2001) 2.40
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J (1987) 2.39
Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem (1997) 2.33
A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol (1997) 2.31
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol (2000) 2.29
Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature (1988) 2.03
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol (2001) 1.92
Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science (1995) 1.90
The MHC-binding and gp120-binding functions of CD4 are separable. Science (1989) 1.77
Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol (1996) 1.72
Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol (1999) 1.63
Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ (2008) 1.61
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res (2001) 1.58
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene (2007) 1.57
A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol (1998) 1.53
Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol (2001) 1.46
The syndrome of neonatal copper deficiency. Pediatrics (1973) 1.45
Functional characterization of the Bcl-2 gene family in the zebrafish. Cell Death Differ (2006) 1.43
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry (2000) 1.34
Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol (1998) 1.34
Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun (1999) 1.33
Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol (1996) 1.33
APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett (1998) 1.32
Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol (1996) 1.32
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature (1992) 1.26
Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain. J Biol Chem (1993) 1.20
Effects of elevated CO2 on grain yield and quality of wheat: results from a 3-year free-air CO2 enrichment experiment. Plant Biol (Stuttg) (2009) 1.15
Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology (1997) 1.14
Disulphide bonds in wheat gluten: cystine peptides derived from gluten proteins following peptic and thermolytic digestion. Z Lebensm Unters Forsch (1995) 1.13
Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res (2001) 1.10
Delineation of the cell-extrinsic apoptosis pathway in the zebrafish. Cell Death Differ (2006) 1.09
Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut (2003) 1.08
Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens (1981) 1.08
Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand J Immunol (2000) 1.07
Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem (1992) 1.06
Analysis and clinical effects of gluten in coeliac disease. Eur J Gastroenterol Hepatol (2001) 1.06
Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine. Cephalalgia (2006) 1.04
Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry (1990) 1.02
Coeliac activity of the gliadin peptides CT-1 and CT-2. Z Lebensm Unters Forsch (1986) 1.00
Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut (2003) 0.99
Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut (2003) 0.99
Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci U S A (1995) 0.99
Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut (2005) 0.98
Immunological assay for the diagnosis of coeliac disease: interaction between purified gluten fractions. Pediatr Res (1980) 0.96
Disulphide bonds in wheat gluten: further cystine peptides from high molecular weight (HMW) and low molecular weight (LMW) subunits of glutenin and from gamma-gliadins. Z Lebensm Unters Forsch (1993) 0.96
Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. J Immunol (1999) 0.95
A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol (1998) 0.95
Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity. Cytokine (1999) 0.95
Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J Immunol (1996) 0.94
Niemann-Pick disease and giant cell transformation of the liver. Acta Paediatr Scand (1971) 0.94
Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Hum Immunol (1993) 0.93
Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding. J Biol Chem (1992) 0.93
Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry (1993) 0.93
Immunoadhesins: principles and applications. Trends Biotechnol (1996) 0.93
Nocturnal acute laryngospasm in children: a possible epileptic phenomenon. J Child Neurol (2000) 0.92
An in-vitro immunological assay for diagnosis of coeliac disease. Lancet (1978) 0.92
Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. J Clin Invest (1995) 0.91
Conformational studies of peptides corresponding to the coeliac-activating regions of wheat alpha-gliadin. Biochem J (1990) 0.90
Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease. Eur J Pediatr (1986) 0.89
Vibrational CD (VCD) and atomic force microscopy (AFM) study of DNA interaction with Cr3+ ions: VCD and AFM evidence of DNA condensation. Biopolymers (2002) 0.89
[Tryptophan content of cereal proteins]. Z Lebensm Unters Forsch (1983) 0.87
Enzymatic oxydation of linoleic acid: formation of bittertasting fatty acids. Z Lebensm Unters Forsch (1977) 0.87
Structural basis of muscarinic acetylcholine receptor subtype diversity. Trends Pharmacol Sci (1988) 0.87
Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice. Gene Ther (2006) 0.87
[Studies on enzymic browning of potatoes (Solanum tuberosum). II. The quantitative relationship between browning and its causative factors (author's transl)]. Z Lebensm Unters Forsch (1977) 0.86
Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth. Trends Pharmacol Sci (1989) 0.86
The effect of manganese(II) on DNA structure: electronic and vibrational circular dichroism studies. Nucleic Acids Res (2004) 0.86
Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1. Cancer Res (2000) 0.85
Intestinal T cell responses to cereal proteins in celiac disease. Dig Dis Sci (2006) 0.85
Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. J Immunol (1994) 0.85
Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. J Immunol (1999) 0.85
Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. Blood (1994) 0.85
Specificities of monoclonal antibodies to domain I of alpha-gliadins. Scand J Gastroenterol (1993) 0.85
Electrosleep therapy in bronchial asthma. Int Arch Allergy Appl Immunol (1969) 0.84
Disulphide bonds in wheat gluten: isolation of a cystine peptide from glutenin. Z Lebensm Unters Forsch (1991) 0.83
Toxicity of different wheat gliadins in coeliac disease. Z Lebensm Unters Forsch (1982) 0.83
In vitro cell-mediated immunologic assay for cow's milk allergy. Pediatrics (1980) 0.83
[Comparative investigations of partial amino acid sequences of prolamines and glutelins from cereals. II. Fractionation of glutelins (author's transl)]. Z Lebensm Unters Forsch (1980) 0.82
Bitter taste of enzymic hydrolysates of casein. I. Isolation, structural and sensorial analysis of peptides from tryptic hydrolysates of beta-casein. Z Lebensm Unters Forsch (1993) 0.82
Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. J Infect Dis (1994) 0.82